Craneware plc (AIM:CRW)
London
· Delayed Price · Currency is GBP · Price in GBX 1,529.20
-0.80 (-0.05%)
Apr 29, 2026, 9:28 AM GMT
Craneware Revenue
Craneware had revenue of $105.72M USD in the half year ending December 31, 2025, with 15.91% growth. This brings the company's revenue in the last twelve months to $211.33M, up 6.68% year-over-year. In the fiscal year ending June 30, 2025, Craneware had annual revenue of $205.66M with 8.66% growth.
Revenue (ttm)
$211.33M
Revenue Growth
+6.68%
P/S Ratio
3.36
Revenue / Employee
$276.25K
Employees
765
Market Cap
527.38M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 205.66M | 16.39M | 8.66% |
| Jun 30, 2024 | 189.27M | 15.25M | 8.76% |
| Jun 30, 2023 | 174.02M | 8.47M | 5.12% |
| Jun 30, 2022 | 165.54M | 89.97M | 119.04% |
| Jun 30, 2021 | 75.58M | 4.09M | 5.72% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.03B |
| Smith & Nephew | 4.58B |
| CVS Group | 692.80M |
| Oxford Biomedica | 168.74M |
| Allergy Therapeutics | 57.29M |
| Spire Healthcare Group | 1.58B |
Craneware News
- 2 months ago - Craneware Earnings Call Transcript: H1 2026 - Transcripts
- 8 months ago - Craneware Earnings Call Transcript: H2 2025 - Transcripts
- 2 years ago - Craneware Earnings Call Transcript: H2 2023 - Transcripts